Histone Deacetylase Inhibitor, Vorinostat, as an Enhancer of Gemcitabine Therapy for Resistant Pancreatic Tumors

被引：0
|
作者：
Green, L. J. [1 ]
Koshkina, N. [1 ]
Curley, S. A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2012年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S156 / S156
页数：1
相关论文
共 50 条
  • [41] The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro
    Sonnemann, Juergen
    Gressmann, Stephanie
    Becker, Sabine
    Wittig, Susan
    Schmudde, Mareike
    Beck, James F.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2010, 66 (03) : 611 - 616
  • [42] Inhibition of cell-mediated immunity by the histone deacetylase inhibitor vorinostat: Implications for therapy of cutaneous T-cell lymphoma
    Stephen, Sasha
    Morrissey, Kelly A.
    Benoit, Bernice M.
    Kim, Ellen J.
    Vittorio, Carmela C.
    Nasta, Sunita D.
    Showe, Louise C.
    Wysocka, Maria
    Rook, Alain H.
    AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (02) : 226 - 228
  • [43] The histone deacetylase inhibitor vorinostat prevents TNFα-induced necroptosis by regulating multiple signaling pathways
    Di Wang
    Ming Zhao
    Guozhu Chen
    Xiang Cheng
    Xiaoxi Han
    Song Lin
    Xuhui Zhang
    Xiaodan Yu
    Apoptosis, 2013, 18 : 1348 - 1362
  • [44] Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells
    Phillip, Cornel J.
    Giardina, Christopher K.
    Bilir, Birdal
    Cutler, David J.
    Lai, Yu-Heng
    Kucuk, Omer
    Moreno, Carlos S.
    BMC CANCER, 2012, 12
  • [45] Anti-tumor effects of the histone deacetylase inhibitor vorinostat on canine urothelial carcinoma cells
    Eto, Shotaro
    Saeki, Kohei
    Yoshitake, Ryohei
    YoshimotoID, Sho
    Shinada, Masahiro
    Ikeda, Namiko
    Kamoto, Satoshi
    Tanaka, Yuiko
    Kato, Daiki
    Maeda, Shingo
    Tsuboi, Masaya
    Chambers, James
    Uchida, Kazuyuki
    Nishimura, Ryohei
    Nakagawa, Takayuki
    PLOS ONE, 2019, 14 (06):
  • [46] The histone deacetylase inhibitor vorinostat prevents TNFα-induced necroptosis by regulating multiple signaling pathways
    Wang, Di
    Zhao, Ming
    Chen, Guozhu
    Cheng, Xiang
    Han, Xiaoxi
    Lin, Song
    Zhang, Xuhui
    Yu, Xiaodan
    APOPTOSIS, 2013, 18 (11) : 1348 - 1362
  • [47] The histone deacetylase inhibitor vorinostat induces calreticulin exposure in childhood brain tumour cells in vitro
    Jürgen Sonnemann
    Stephanie Greßmann
    Sabine Becker
    Susan Wittig
    Mareike Schmudde
    James F. Beck
    Cancer Chemotherapy and Pharmacology, 2010, 66 : 611 - 616
  • [48] The combination of the histone deacetylase inhibitor vorinostat and synthetic triterpenoids reduces tumorigenesis in mouse models of cancer
    Kim Tran
    Risingsong, Renee
    Royce, Darlene B.
    Williams, Charlotte R.
    Sporn, Michael B.
    Pioli, Patricia A.
    Gediya, Lalji K.
    Njar, Vincent C.
    Liby, Karen T.
    CARCINOGENESIS, 2013, 34 (01) : 199 - 210
  • [49] Vorinostat, a histone deacetylase inhibitor, suppresses dendritic cell function and ameliorates experimental autoimmune encephalomyelitis
    Ge, Zhenzhen
    Da, Yurong
    Xue, Zhenyi
    Zhang, Kai
    Zhuang, Hao
    Peng, Meiyu
    Li, Yan
    Li, Wen
    Simard, Alain
    Hao, Junwei
    Yao, Zhi
    Zhang, Rongxin
    EXPERIMENTAL NEUROLOGY, 2013, 241 : 56 - 66
  • [50] Genistein cooperates with the histone deacetylase inhibitor vorinostat to induce cell death in prostate cancer cells
    Cornel J Phillip
    Christopher K Giardina
    Birdal Bilir
    David J Cutler
    Yu-Heng Lai
    Omer Kucuk
    Carlos S Moreno
    BMC Cancer, 12
12345